HK1036417A1 - A non-stustained release, non-chewable pharmaceutical tablet composition - Google Patents

A non-stustained release, non-chewable pharmaceutical tablet composition

Info

Publication number
HK1036417A1
HK1036417A1 HK01107510A HK01107510A HK1036417A1 HK 1036417 A1 HK1036417 A1 HK 1036417A1 HK 01107510 A HK01107510 A HK 01107510A HK 01107510 A HK01107510 A HK 01107510A HK 1036417 A1 HK1036417 A1 HK 1036417A1
Authority
HK
Hong Kong
Prior art keywords
stustained
release
tablet composition
pharmaceutical tablet
chewable pharmaceutical
Prior art date
Application number
HK01107510A
Other languages
English (en)
Inventor
Alice C Martino
Ashley H Bates
Walter Morozowich
E John Lee
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1036417(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HK1036417A1 publication Critical patent/HK1036417A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
HK01107510A 1998-06-11 2001-10-29 A non-stustained release, non-chewable pharmaceutical tablet composition HK1036417A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8896098P 1998-06-11 1998-06-11
PCT/US1999/011798 WO1999063970A1 (en) 1998-06-11 1999-06-07 Delavirdine tablet formulation

Publications (1)

Publication Number Publication Date
HK1036417A1 true HK1036417A1 (en) 2002-01-04

Family

ID=22214517

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107510A HK1036417A1 (en) 1998-06-11 2001-10-29 A non-stustained release, non-chewable pharmaceutical tablet composition

Country Status (21)

Country Link
US (3) US6177101B1 (ja)
EP (1) EP1083885B1 (ja)
JP (1) JP4827296B2 (ja)
KR (2) KR20070040426A (ja)
CN (1) CN1237958C (ja)
AT (1) ATE349203T1 (ja)
AU (1) AU753241C (ja)
BR (1) BR9910481A (ja)
CA (1) CA2328703C (ja)
CY (1) CY1105924T1 (ja)
DE (1) DE69934582T2 (ja)
DK (1) DK1083885T3 (ja)
EA (1) EA004311B1 (ja)
ES (1) ES2277682T3 (ja)
HK (1) HK1036417A1 (ja)
HU (1) HUP0102206A3 (ja)
NZ (1) NZ508762A (ja)
PL (1) PL200163B1 (ja)
PT (1) PT1083885E (ja)
WO (1) WO1999063970A1 (ja)
ZA (1) ZA200006090B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910481A (pt) * 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua
CA2395331C (en) 1999-12-23 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) * 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
WO2003020736A1 (en) * 2001-08-28 2003-03-13 Pharmacia Corporation Crystaline clindamycin free base
DE10164510A1 (de) 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US20050163839A1 (en) * 2003-01-29 2005-07-28 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
JP2006522099A (ja) * 2003-04-04 2006-09-28 ファルマシア コーポレーション 複合粒状体からなる経口徐放性圧縮錠
BRPI0411429A (pt) 2003-06-13 2006-07-25 Idh Holding Aps tratamento de sintomas associados com vaginose bacteriana
WO2005004763A1 (en) * 2003-07-01 2005-01-20 Pharmacia & Upjohn Company Llc. Diffusion layer modulated solids
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) * 2004-06-17 2005-12-22 Lentz David J Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2008012991A1 (fr) 2006-07-27 2008-01-31 Kabushiki Kaisha Kobe Seiko Sho Dispositif de connexion et installation de malaxage possédant un dispositif de malaxage et un dispositif d'entraînement connectés l'un à l'autre par le dispositif de connexion
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) * 2009-09-28 2014-04-15 Continuous MotionFlow, LLC Passive motion machine with integrated mechanical DVT prophylactic therapy
EP3064064A1 (en) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CA2888883A1 (en) 2012-10-18 2014-04-24 Abbvie Inc. Formulations of pyrimidinedione derivative compounds
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
US11857543B2 (en) 2013-06-13 2024-01-02 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP2021523882A (ja) * 2018-05-15 2021-09-09 ジエンス ハンセン ファーマセウティカル グループ カンパニー リミテッド 低分子ｅｇｆｒ阻害剤を含む医薬組成物及びその製造方法
CN108619104A (zh) * 2018-06-29 2018-10-09 哈尔滨珍宝制药有限公司 一种基于盐酸克林霉素的药物组合物及其制备方法
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
EP0319074B1 (en) * 1987-11-30 1992-01-29 Brocades Pharma B.V. Pharmaceutical composition and process for its preparation
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
CA2007764C (en) * 1989-02-24 1999-11-30 Joseph Michael Beaurline Salsalate tablet
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
IL96603A (en) 1989-12-13 1998-02-08 Lilly Co Eli Antibacterial glycopeptide derivativesProcess for their preparation and pharmaceutical preparations containing the same
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
ES2164147T3 (es) 1994-04-15 2002-02-16 Upjohn Co Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina.
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
BR9910481A (pt) * 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua

Also Published As

Publication number Publication date
KR100724016B1 (ko) 2007-05-31
AU753241C (en) 2003-05-08
KR20070040426A (ko) 2007-04-16
EP1083885A1 (en) 2001-03-21
AU4213499A (en) 1999-12-30
DE69934582D1 (de) 2007-02-08
CN1301149A (zh) 2001-06-27
BR9910481A (pt) 2001-01-09
JP2002517430A (ja) 2002-06-18
CA2328703C (en) 2007-10-30
PL344328A1 (en) 2001-10-22
JP4827296B2 (ja) 2011-11-30
US7108864B1 (en) 2006-09-19
HUP0102206A2 (hu) 2002-03-28
HUP0102206A3 (en) 2002-12-28
DE69934582T2 (de) 2007-10-04
ES2277682T3 (es) 2007-07-16
PL200163B1 (pl) 2008-12-31
DK1083885T3 (da) 2007-02-26
NZ508762A (en) 2003-07-25
US20060257476A1 (en) 2006-11-16
EP1083885B1 (en) 2006-12-27
PT1083885E (pt) 2007-01-31
CY1105924T1 (el) 2011-04-06
KR20010052717A (ko) 2001-06-25
WO1999063970A1 (en) 1999-12-16
AU753241B2 (en) 2002-10-10
EA200100024A1 (ru) 2001-06-25
CN1237958C (zh) 2006-01-25
EA004311B1 (ru) 2004-02-26
ZA200006090B (en) 2001-10-29
US6177101B1 (en) 2001-01-23
CA2328703A1 (en) 1999-12-16
ATE349203T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
HK1036417A1 (en) A non-stustained release, non-chewable pharmaceutical tablet composition
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
HUP0003058A3 (en) Soya extract, process for its preparation and pharmaceutical composition
AU1729397A (en) Process to prepare soluble delivery systems using volatile salts
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
AU7196096A (en) Long-lasting release Nifedipine preparation
HUP0100568A3 (en) 11beta-halogen-7alpha-substituted estratrienes, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
CA2214895A1 (en) Improved pharmaceutical composition comprising fenofibrate
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
GR3031568T3 (en) Cyclosporin containing composition and process for the preparation thereof
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
ZA973850B (en) Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
ZA971746B (en) Taxoids, their preparation and pharmaceutical compositions containing them.
HUP9702480A3 (en) New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
HU9700989D0 (en) Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them
HU9603388D0 (en) New taxoids, preparation thereof and pharmaceutical compositions containing them
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190606